Provided is a prophylactic and/or therapeutic agent for Porphyromonas gingivalis infection. A prophylactic and/or therapeutic agent for Porphyromonas gingivalis infection, comprising killed Enterococcus faecalis. A prophylactic and/or therapeutic agent for a disease attributable to Porphyromonas gingivalis, comprising killed Enterococcus faecalis. A medicine or food for prevention and/or treatment of Porphyromonas gingivalis infection, comprising killed Enterococcus faecalis. A medicine or food for prevention and/or treatment of a disease attributable to Porphyromonas gingivalis, comprising killed Enterococcus faecalis. A growth inhibitor for Porphyromonas gingivalis, comprising killed Enterococcus faecalis. An inhibitor for gingipain activity, comprising killed Enterococcus faecalis.
One aspect of the present invention provides an anti-obesity agent, an anti-dementia agent, a deodorant, an anti-aging agent, an anti-glycation agent, an anti-type I allergy agent, a hypotensive agent, a flavor improving agent, a muscle enhancing agent, and a bone metabolism improving agent which contain a bagasse decomposition extract as an active ingredient.
Provided is a viscous nutritional composition that can be used without effort two or three times per day by, for example, a patient undergoing rehabilitation or long-term treatment. This viscous nutritional composition contains nutrients that include proteins, lipids, and carbohydrates. The density (quantity of heat/g) of the viscous nutritional composition is 0.9–1.1 kcal/g, the quantity of heat per unit is 450–550 kcal/unit, and two or three units are to be used per person per day.
Provided is a liquid nutritional composition which is in a small volume, has high energy, and allows easy ingestion of a variety of nutrients such as protein, lipids, saccharides, dietary fiber, vitamins, minerals, and vitamin-like substances. Provided is a liquid nutritional composition which contains protein, fat, saccharides, and dietary fiber and has a calorie content of 1.7-2.3 kcal/mL, a viscosity at 25°C of 25-40 mPa·s, and an osmotic pressure of 420-500 mOsm/L, wherein: the composition contains 6.2-6.8 mass% of the protein, 6.4-7.0 mass% of lipids, 18-24 mass% of saccharides, and 1.5-2.5 mass% of dietary fiber; and the dietary fiber contains, in the total dietary fiber, 20-35 mass% of water-soluble dietary fiber, which has a weight average molecular weight of 15,000-25,000 and viscosity of a 5 mass% solution of 10 mPa·s or less.
Provided is a growth inhibitor for Clostridioides difficile. A growth inhibitor for Clostridioides difficile, comprising killed Enterococcus faecalis. Also provided are a parenteral pharmaceutical preparation, a bactericide, a disinfectant, an antibacterial agent, a sanitizer or a detergent for inhibiting the growth of Clostridioides difficile.
Provided is an agent for the prevention and/or treatment of Porphyromonas gingivalis infection. An agent for the prevention and/or treatment of Porphyromonas gingivalis infection that contains killed Enterococcus faecalis. An agent for the prevention and/or treatment of a disease caused by Porphyromonas gingivalis that contains killed Enterococcus faecalis. A drug or a food for the prevention and/or treatment of Porphyromonas gingivalis infection that contains killed Enterococcus faecalis. A drug or a food for the prevention and/or treatment of a disease caused by of Porphyromonas gingivalis that contains killed Enterococcus faecalis. A Porphyromonas gingivalis growth inhibitor that contains killed Enterococcus faecalis. A gingipain activity inhibitor that contains killed Enterococcus faecalis.
Provided is an agent for the prevention and/or treatment of Porphyromonas gingivalis infection. An agent for the prevention and/or treatment of Porphyromonas gingivalis infection that contains killed Enterococcus faecalis. An agent for the prevention and/or treatment of a disease caused by Porphyromonas gingivalis that contains killed Enterococcus faecalis. A drug or a food for the prevention and/or treatment of Porphyromonas gingivalis infection that contains killed Enterococcus faecalis. A drug or a food for the prevention and/or treatment of a disease caused by of Porphyromonas gingivalis that contains killed Enterococcus faecalis. A Porphyromonas gingivalis growth inhibitor that contains killed Enterococcus faecalis. A gingipain activity inhibitor that contains killed Enterococcus faecalis.
Provided is a food material capable of preparing a mixer porridge-like food or a jelly thereof which is not subject to the formation of lumps (undissolved lumps of flour). Provided is granulated rice flour. The rice flour may be granulated together with a gelling agent and a starch degrading enzyme. A method for producing granulated rice flour includes spraying a liquid in which rice powder is dissolved to a mixture of rice powder, a gelling agent and a starch degrading enzyme. A food composition contains granulated rice flour. A mixer porridge-like food or a jelly thereof is obtained by dispersing granulated rice flour in a liquid.
In order to provide a nutritional composition that has a shape that is easy to administer or ingest, that does not exhibit a marked reduction in viscosity under acidity (when mixed with gastric juices), and that has excellent nutrients, the nutritional composition according to one embodiment of the present invention includes casein, collagen, and a thickener, where the thickener does not have a gelling property that is exhibited when cooled after heating, and is soluble in an acid.
A23L 29/238 - Foods or foodstuffs containing additivesPreparation or treatment thereof containing gelling or thickening agents of vegetable origin from seeds, e.g. locust bean gum or guar gum
A23L 29/256 - Foods or foodstuffs containing additivesPreparation or treatment thereof containing gelling or thickening agents of vegetable origin from seaweeds, e.g. alginates, agar or carrageenan
A23L 29/269 - Foods or foodstuffs containing additivesPreparation or treatment thereof containing gelling or thickening agents of microbial origin, e.g. xanthan or dextran
The present invention provides a technical means for efficiently producing a polyphenol-containing composition from grass-based biomass. More specifically, the present invention provides a method for producing a polyphenol-containing composition derived from grass-based biomass, the method including: (1) a step in which an extraction liquid is obtained by bringing grass-based biomass into contact with an alkaline aqueous solution of 60°C or higher; (2) a step in which the extraction liquid obtained in step (1) is cooled to 60°C or lower to obtain a cooled extract solution; (3) a step in which the pH of the cooled extraction liquid obtained in step (2) is adjusted to a pH of 3.2-4.5, and the cooled extraction liquid is reacted with an enzyme having cellobiohydrolase activity and xylanase activity to obtain an enzyme-reacted solution; (4) a step in which a clarified liquid is obtained by rough filtration of the enzyme-reacted solution obtained in step (3); (5) a step in which the clarified liquid obtained in step (4) is passed through a column filled with an aromatic synthetic adsorbent composed of an aromatic resin subjected to a special treatment for increasing the specific surface area thereof, and the component adsorbed to the aromatic synthetic adsorbent is eluted using a mixed solvent of ethanol and water so as to obtain an eluted fraction as a polyphenol-containing composition.
AGENT FOR ENHANCING APPETITE IN ABALONE AND SEA URCHIN, AGENT FOR PROMOTING SYNTHESIS OF NEUROPEPTIDE Y IN ABALONE AND SEA URCHIN, AND METHODS FOR PRODUCING SAME
The present invention relates to an agent which contains an extract derived from bagasse as an active ingredient, and which is for enhancing appetite in abalone and sea urchin.
A23K 10/37 - Animal feeding-stuffs from material of plant origin, e.g. roots, seeds or hayAnimal feeding-stuffs from material of fungal origin, e.g. mushrooms from waste material
A23K 50/80 - Feeding-stuffs specially adapted for particular animals for aquatic animals, e.g. fish, crustaceans or molluscs
The present invention pertains to a digestive lipase activity inhibitor containing, as an active ingredient, at least one selected from the group consisting of linoleic acid and oleic acid.
A61K 31/231 - Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin of acids having a carboxyl group bound to a chain of seven or more carbon atoms having one or two double bonds
One aspect of the present invention provides an anti-obesity agent, an anti-dementia agent, a deodorant, an anti-aging agent, an anti-glycation agent, an anti-type I allergy agent, a hypotensive agent, a flavor improving agent, a muscle enhancing agent, and a bone metabolism improving agent which contain a bagasse decomposition extract as an active ingredient.
Provided is a Clostridiodes difficile growth inhibitor. A Clostridiodes difficile growth inhibitor containing killed Enterococcus faecalis. Also provided are a parenteral pharmaceutical preparation, a bactericide, a disinfectant, an antibacterial agent, a sanitizer, or a detergent for inhibiting growth of Clostridiodes difficile.
A61K 35/744 - Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
A01N 63/20 - BacteriaSubstances produced thereby or obtained therefrom
A01P 1/00 - DisinfectantsAntimicrobial compounds or mixtures thereof
A61K 8/99 - Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof, of undetermined constitution from microorganisms other than algae or fungi, e.g. protozoa or bacteria
A61L 15/36 - Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons containing microorganisms
Provided is a Clostridiodes difficile growth inhibitor. A Clostridiodes difficile growth inhibitor containing killed Enterococcus faecalis. Also provided are a parenteral pharmaceutical preparation, a bactericide, a disinfectant, an antibacterial agent, a sanitizer, or a detergent for inhibiting growth of Clostridiodes difficile.
A61K 35/744 - Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
A61K 8/97 - Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof, of undetermined constitution from algae, fungi, lichens or plantsCosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof, of undetermined constitution from derivatives thereof
A61L 15/36 - Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons containing microorganisms
The present invention provides a dextrin powder at a low cost which may be used as a component of thickeners that are good in dispersibility in moisture, etc. A dextrin powder obtainable by spray drying a dextrin solution, wherein dextrin particles with a length to thickness ratio of 3 or more are contained in a proportion of 3% or more (as based on the number of the particles). A thickener comprising the dextrin powder. A food comprising the dextrin powder.
A23L 29/269 - Foods or foodstuffs containing additivesPreparation or treatment thereof containing gelling or thickening agents of microbial origin, e.g. xanthan or dextran
A23F 3/14 - Tea preparations, e.g. using additives
20.
Anti-obesity agent, anti-dementia agent, deodorant, anti-aging agent, anti-glycation agent, anti-type I allergy agent, hypotensive agent, flavor improving agent, muscle enhancing agent, and bone metabolism improving agent
One aspect of the present invention provides an anti-obesity agent, an anti-dementia agent, a deodorant, an anti-aging agent, an anti-glycation agent, an anti-type I allergy agent, a hypotensive agent, a flavor improving agent, a muscle enhancing agent, and a bone metabolism improving agent which contain a bagasse decomposition extract as an active ingredient.
A61K 31/7016 - Disaccharides, e.g. lactose, lactulose
A61P 25/26 - Psychostimulants, e.g. nicotine, cocaine
A23L 33/125 - Modifying nutritive qualities of foodsDietetic productsPreparation or treatment thereof using additives containing carbohydrate syrupsModifying nutritive qualities of foodsDietetic productsPreparation or treatment thereof using additives containing sugarsModifying nutritive qualities of foodsDietetic productsPreparation or treatment thereof using additives containing sugar alcoholsModifying nutritive qualities of foodsDietetic productsPreparation or treatment thereof using additives containing starch hydrolysates
23.
PREVENTIVE AND/OR THERAPEUTIC AGENT FOR CLOSTRIDIUM DIFFICILE INFECTION
Provided is a novel preventive and/or therapeutic agent for Clostridium difficile infection. It has been discovered that bacteria belonging to the genus Enterococcus are capable of preventing and/or curing Clostridium difficile infection. Disclosed herein are: an agent that is for preventing and/or curing Clostridium difficile infection and that contains a bacterium belonging to the genus Enterococcus; a medicinal product that is for preventing and/or curing Clostridium difficile infection and that contains a bacterium belonging to the genus Enterococcus; and a food product that is for preventing and/or curing Clostridium difficile infection and that contains a bacterium belonging to the genus Enterococcus.
Provided, at a low cost, is a dextrin powder that can be used as a component for a thickener having good dispersibility in water or the like. This dextrin powder is obtained by spray-drying a dextrin solution, the powder containing 3% or more dextrin particles (count-based ratio of particles) with a ratio of length over thickness of 3 or greater. Also provided is a thickener containing the dextrin powder and a food product containing the dextrin powder.
A23L 29/30 - Foods or foodstuffs containing additivesPreparation or treatment thereof containing carbohydrate syrupsFoods or foodstuffs containing additivesPreparation or treatment thereof containing sugarsFoods or foodstuffs containing additivesPreparation or treatment thereof containing sugar alcohols, e.g. xylitolFoods or foodstuffs containing additivesPreparation or treatment thereof containing starch hydrolysates, e.g. dextrin
Provided, at a low cost, is a dextrin powder that can be used as a component for a thickener having good dispersibility in water or the like. This dextrin powder is obtained by spray-drying a dextrin solution, the powder containing 3% or more dextrin particles (count-based ratio of particles) with a ratio of length over thickness of 3 or greater. Also provided is a thickener containing the dextrin powder and a food product containing the dextrin powder.
A23L 29/30 - Foods or foodstuffs containing additivesPreparation or treatment thereof containing carbohydrate syrupsFoods or foodstuffs containing additivesPreparation or treatment thereof containing sugarsFoods or foodstuffs containing additivesPreparation or treatment thereof containing sugar alcohols, e.g. xylitolFoods or foodstuffs containing additivesPreparation or treatment thereof containing starch hydrolysates, e.g. dextrin
The present invention provides dextrin particles at a low cost which may be used as a component of thickeners that are good in dispersibility in moisture, etc. Fibrous dextrin particles. A thickener comprising the fibrous dextrin particles. A food comprising the fibrous dextrin particles. A method of preparing fibrous dextrin particles, comprising spray drying a dextrin solution with a viscosity of 100 mPa·s or more.
One aspect of the present invention is a method for producing a polyphenol composition from bagasse, which comprises: a step wherein bagasse is pre-treated with use of at least one alkaline solution that is selected from the group consisting of an aqueous sodium hydroxide solution, an aqueous potassium hydroxide solution and an aqueous ammonia solution, thereby obtaining a pretreatment liquid; a step wherein after the pH of the pretreatment liquid is adjusted to an acidic value with use of hydrochloric acid, the pretreatment liquid is filtered and the filtrate is subsequently recovered; and a step wherein the filtrate is passed through a column that is filled with an aromatic synthetic adsorbent and the component adsorbed on the aromatic synthetic adsorbent is subsequently eluted by means of a mixed solvent of ethanol and water, thereby obtaining the eluted fraction as a polyphenol composition.
C07G 1/00 - Low-molecular-weight derivatives of lignin
A23L 35/00 - Foods or foodstuffs not provided for in groups Preparation or treatment thereof
C07B 63/00 - PurificationSeparation specially adapted for the purpose of recovering organic compoundsStabilisationUse of additives
C07C 51/47 - SeparationPurificationStabilisationUse of additives by solid-liquid treatmentSeparationPurificationStabilisationUse of additives by chemisorption
C07C 59/52 - Unsaturated compounds containing hydroxy or O-metal groups a hydroxy or O-metal group being bound to a carbon atom of a six-membered aromatic ring
C07C 59/64 - Unsaturated compounds containing ether groups, groups, groups, or groups containing six-membered aromatic rings
31.
ANTI-OBESITY AGENT, ANTI-DEMENTIA AGENT, DEODORANT, ANTI-AGING AGENT, ANTI-GLYCATION AGENT, ANTI-TYPE I ALLERGY AGENT, HYPOTENSIVE AGENT, FLAVOR IMPROVING AGENT, MUSCLE ENHANCING AGENT, AND BONE METABOLISM IMPROVING AGENT
One aspect of the present invention provides an anti-obesity agent, an anti-dementia agent, a deodorant, an anti-aging agent, an anti-glycation agent, an anti-type I allergy agent, a hypotensive agent, a flavor improving agent, a muscle enhancing agent, and a bone metabolism improving agent which contain a decomposition extract of bagasse as an active ingredient.
A61P 21/00 - Drugs for disorders of the muscular or neuromuscular system
A61P 25/28 - Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
Provided is a novel agent for the prevention and/or treatment of Pseudomonas aeruginosa infection. It was discovered that bacteria belonging to the genus Enterococcus can prevent and/or treat Pseudomonas aeruginosa infection. An agent for the prevention and/or treatment of Pseudomonas aeruginosa infection, the agent containing bacteria belonging to the genus Enterococcus. A medicine for the prevention and/or treatment of Pseudomonas aeruginosa infection, the medicine containing bacteria belonging to the genus Enterococcus. A food for the prevention and/or treatment of Pseudomonas aeruginosa infection, the food containing bacteria belonging to the genus Enterococcus.
Provided is a novel agent for the prevention and/or treatment of Pseudomonas aeruginosa infection. It was discovered that bacteria belonging to the genus Enterococcus can prevent and/or treat Pseudomonas aeruginosa infection. An agent for the prevention and/or treatment of Pseudomonas aeruginosa infection, the agent containing bacteria belonging to the genus Enterococcus. A medicine for the prevention and/or treatment of Pseudomonas aeruginosa infection, the medicine containing bacteria belonging to the genus Enterococcus. A food for the prevention and/or treatment of Pseudomonas aeruginosa infection, the food containing bacteria belonging to the genus Enterococcus.
CA 03088601 2020-07-15 34 Abstract Provide is a novel prophylactic and/or therapeutic agent for Streptococcus pneumoniae infection. It was found that a bacterium belonging to the genus Enterococcus can prevent and/or treat Streptococcus pneumoniae infection. The prophylactic and/or therapeutic agent for Streptococcus pneumoniae infection, comprises a bacterium belonging to the genus Enterococcus. Also provided are: a medicine for prevention and/or treatment of Streptococcus pneumoniae infection, comprising a bacterium belonging to the genus Enterococcus; and a food for prevention and/or treatment of Streptococcus pneumoniae infection, comprising a bacterium belonging to the genus Enterococcus. Date Recue/Date Received 2020-07-15
Provided is a novel prophylactic and/or therapeutic agent for a pneumococcal infection. It is found that bacteria belonging to the genus enterococcus can prevent and/or treat a pneumococcal infection. Provided is a prophylactic and/or therapeutic agent for a pneumococcal infection, said agent containing bacteria belonging to the genus enterococcus. Provided is a prophylactic and/or therapeutic medicine for a pneumococcal infection, said medicine containing bacteria belonging to the genus enterococcus. Provided is a prophylactic and/or therapeutic food for a pneumococcal infection, said food containing bacteria belonging to the genus enterococcus.
One embodiment of the present invention provides an anti-I-type allergy agent that contains p-coumaric acid as an active ingredient. Further, another embodiment of the present invention provides an anti-dementia agent that contains p-coumaric acid as an active ingredient.
Provided is a novel MRSA infection protective agent. Bacteria belonging to the genus Enterococcus were found to be able to protect against MRSA infection. This MRSA infection protective agent contains bacteria belonging to the genus Enterococcus. Also provided are a medicine and a food, which are for protecting MRSA infection and contain bacteria belonging to the genus Enterococcus.
Provided is a novel MRSA infection protective agent. Bacteria belonging to the genus Enterococcus were found to be able to protect against MRSA infection. This MRSA infection protective agent contains bacteria belonging to the genus Enterococcus. Also provided are a medicine and a food, which are for protecting MRSA infection and contain bacteria belonging to the genus Enterococcus.
Dextrin particles usable as a component of thickeners having satisfactory dispersibility in water, etc. are inexpensively provided. The present invention relates to: fibrous dextrin particles; a thickener comprising the fibrous dextrin particles; a food containing the fibrous dextrin particles; and a method for producing the fibrous dextrin particles which comprises spray-drying a dextrin solution having a viscosity of 100 mPa·s or higher.
Dextrin particles usable as a component of thickeners having satisfactory dispersibility in water, etc. are inexpensively provided. The present invention relates to: fibrous dextrin particles; a thickener comprising the fibrous dextrin particles; a food containing the fibrous dextrin particles; and a method for producing the fibrous dextrin particles which comprises spray-drying a dextrin solution having a viscosity of 100 mPa∙s or higher.
The present invention provides a gelling composition for preparing a gelatinous food which do not dissolve even when reheated (e.g., dysphagia diet).
The present invention provides a gelling composition for preparing a gelatinous food which retains its original shape even when reheated, wherein the gelling composition comprises a water-soluble polymer capable of forming a thermo-irreversible gel. Also provided is a method of gelling a food and enhancing the shape-retaining property of the food against reheating by using the above-described gelling composition, as well as a method of preparing a gelatinous food which retains its original shape even when reheated by using the above-described gelling composition.
A23L 29/20 - Foods or foodstuffs containing additivesPreparation or treatment thereof containing gelling or thickening agents
A23L 33/00 - Modifying nutritive qualities of foodsDietetic productsPreparation or treatment thereof
A23L 29/212 - StarchModified starchStarch derivatives, e.g. esters or ethers
A23L 29/256 - Foods or foodstuffs containing additivesPreparation or treatment thereof containing gelling or thickening agents of vegetable origin from seaweeds, e.g. alginates, agar or carrageenan
A23L 29/269 - Foods or foodstuffs containing additivesPreparation or treatment thereof containing gelling or thickening agents of microbial origin, e.g. xanthan or dextran
A23L 29/238 - Foods or foodstuffs containing additivesPreparation or treatment thereof containing gelling or thickening agents of vegetable origin from seeds, e.g. locust bean gum or guar gum
A23L 33/16 - Inorganic salts, minerals or trace elements
42.
Method for producing a sugar crystal-containing liquid
PURPOSE: An object of the present invention is to provide a method for producing a sugar crystal-containing liquid with good reproducibility, wherein crystallization is enhanced, it is unnecessary to add seed crystals which may affect the number of grains and a size of the crystals, and graining conditions are stable.
CONSTITUTION: The present invention is a method for producing a sugar crystal-containing liquid, wherein the method comprises steps of preparing a liquid supersaturated with sugar; and applying a shearing force to the liquid, characterized in that the step of applying the shearing force comprises exerting a pressure higher than atmospheric pressure on the liquid to make the liquid pass through a narrow space.
To provide a gelling composition for manufacturing a gelled foodstuff (e.g., deglutition adjustment food) that does not dissolve even when reheated. Provided is a gelling composition for manufacturing a gelled foodstuff that holds shape even when reheated after being manufactured, wherein the gelling composition contains a water-soluble polymer capable of forming a heat-irreversible gel. Also provided are a method for gelling a foodstuff and improving the ability of the foodstuff to retain shape in response to reheating after the foodstuff has been manufactured, and a method for manufacturing a gelled food item which holds shape even when reheated after being manufactured, using the gelling composition.
05 - Pharmaceutical, veterinary and sanitary products
Goods & Services
Dietary supplements for humans containing nutrients of
vitamins, minerals, etc. made mainly from Coenzyme Q10,
alpha lipoic acid, chromium, etc. in the form of pill,
granulated powder, capsule, powder, block, liquid, jelly or
paste; dietetic food adapted for medical purposes, namely
foodstuffs in the form of powder made mainly from
polysaccharide thickener and dextrin to add thickness for
patients with swallowing disorders.
05 - Pharmaceutical, veterinary and sanitary products
Goods & Services
Dietary supplements for humans; dietetic food adapted for
medical purposes, namely, foodstuffs in the form of powder
made mainly from polysaccharide thickener and dextrin to add
thickness for patients with swallowing disorders.
The present invention relates to a composition for external application, which contains at least one component selected from the group consisting of trehalulose, isomaltulose and reduced isomaltulose.
The present invention relates to a flavor improver comprising a brown sugar aromatic fraction, wherein the brown sugar aromatic fraction comprises an eluted fraction which is produced by a production method comprising the steps of: concentrating a sugar cane squeeze by heating until the Brix value (Bx) becomes 65 to 82, thereby producing a concentrated liquor; distilling the concentrated liquor while heating under ambient pressure, then collecting steam that is generated in a temperature range from 110 to 130°C, and then cooling the collected steam to produce a distillate; and allowing the distillate to pass through a column in which a synthetic adsorbent has been filled as an immobilization carrier, and then allowing an adsorbed component, which is adsorbed onto the synthetic adsorbent, to elute with an elution solvent, thereby producing the eluted fraction.
[Problem] To provide a method for producing a sugar-crystal-containing fluid, said method eliminating the need to add seed crystals, which accelerate crystallization and have an influence on the number of divisions or the size of crystals, and ensuring stable crystallization conditions and excellent reproducibility. [Solution] A method for producing a sugar-crystal-containing fluid which includes a step for preparing a solution that contains a sugar in a supersaturated state and a step for applying a shear force to the solution, wherein the step for applying a shear force includes applying a pressure exceeding the atmospheric pressure to the solution and thus passing the solution through a narrow passageway.
The present invention provides an enteral nutritional composition with which the labor of administering water between meals can be saved. The enteral nutritional composition comprises proteins, carbohydrates and lipids, with the calories per ml of the composition being less than 1 kcal and the moisture content being 30 percent by mass or more.
The present invention provides a Peyer's patch activator containing polysaccharides obtained from sugar cane as active components. The polysaccharides mainly comprise α-glucans, and have a peak molecular weight in the range of 720,000-1,080,000. The ratio of glucose, relative to the total constituent saccharides, is equal to or greater than 80%. The ratio of non-reducing terminal glucose is 20-30%, and the ratio of α-1,6-bonded glucose is 15-25%.
The present invention provides a stevia preparation comprising a stevia sweetening agent containing rebaudioside A at a content of 95% or more, a sugar cane-derived extract (a) in an amount of 0.25 to 5.15 parts by mass relative to 100 parts by mass of the stevia sweetening agent, a sugar cane-derived extract (b) in an amount of 0.06 to 2.50 parts by mass relative to 100 parts by mass of the stevia sweetening agent, and γ-aminobutyric acid in an amount of 0.002 to 12.5 parts by mass relative to 100 parts by mass of the stevia sweetening agent.
A23L 1/22 - Spices; Flavouring agents or condiments; Artificial sweetening agents; Table salts; Dietetic salt substitutes
A61K 31/197 - Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
A61K 47/08 - Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen
A61K 47/12 - Carboxylic acidsSalts or anhydrides thereof
A61K 47/18 - AminesAmidesUreasQuaternary ammonium compoundsAmino acidsOligopeptides having up to five amino acids
55.
METHOD FOR PRODUCING SOLID MATERIAL FROM SACCHARIDE SOLUTION, AND SOLID MATERIAL
[Problem] The purpose of the present invention is to provide: a method for producing a solid material from a saccharide solution; and a solid material produced from a saccharide solution. [Solution] The present invention provides a method for producing an isomaltulose-containing solid material by allowing an enzyme capable of producing isomaltulose from sucrose to act on a sucrose solution to produce an isomaltulose-containing saccharide solution and producing the isomaltulose-containing solid material from the saccharide solution. The method involves crystallizing isomaltulose crystals having a median diameter of 5-60 μm in the saccharide solution, wherein the median diameter is measured by a laser diffraction particle size distribution measurement. The method also involves spray-drying the saccharide solution containing the isomaltulose crystals at a hot air temperature of 50-95˚C. The present invention also provides a solid material containing 70-90 mass% of isomaltulose and an amorphous saccharide solution. The solid material is characterized by having a spherical shape.
The purpose of the present invention is to provide a method for producing a solid matter from a saccharide solution containing isomaltulose. A method wherein a sucrose solution is treated with an enzyme, which is capable of synthesizing isomaltulose from sucrose, to give an isomaltulose-containing saccharide solution and then a solid matter is produced from the saccharide solution, said method comprising: heating the saccharide solution to thereby adjust the solid content of the saccharide solution to 77-96 mass%; subjecting the thus adjusted solution to a crystal nucleation treatment by applying a shear force thereto while maintaining the same at 65-120oC; and then cooling the treated matter thus obtained.
Provided is a method for producing a natural red pigment, particularly a plant-based red pigment. The method involves producing a red pigment by reacting a protein hydrolysis product with an iridoid compound having a carboxyl group at position 4 of an iridoid skeleton. The protein hydrolysis product has an amino acid content of at least 35 wt% in terms of the protein hydrolysis product dry weight, and according to ninhydrin assay, at least 50 wt% of the amino acid is glutamic acid and aspartic acid and the ratio of the leucine weight to the total weight of the glutamic acid and aspartic acid is no greater than 8 wt%. It is also possible to react the protein hydrolysis product and taurine or a taurine-containing substance with the iridoid compound.
The present invention provides an enteral nutritional composition with which the labor of administering water between meals can be saved. The enteral nutritional composition comprises proteins, carbohydrates and lipids, with the calories per ml of the composition being less than 1 kcal and the moisture content being 30 percent by mass or more.
A23L 1/304 - Inorganic salts, minerals, trace elements
A23L 1/09 - containing carbohydrate syrups; containing sugars; containing sugar alcohols, e.g. xylitol; containing starch hydrolysates, e.g. dextrin (A23L 1/76, A23L 1/236 take precedence);;
59.
Composition for reducing oxidative stress and/or side effects occurring during cancer chemotherapy or improving nutritional status during cancer chemotherapy
A61K 45/06 - Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
A61K 31/197 - Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
The present invention provides an enteral nutritional composition with which the labor of administering water between meals can be saved. The enteral nutritional composition comprises proteins, carbohydrates and lipids, with the calories per ml of the composition being less than 1 kcal and the moisture content being 30 percent by mass or more.
A61K 36/00 - Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
Disclosed is an enteral nutritional composition which can save the effort of administrating dinking water between doses of the composition. The enteral nutritional composition comprises a protein, a carbohydrate and a lipid, has less than 1 kcal per mL, and has a water content of 30 mass% or more.
A61K 36/00 - Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
Disclosed is a compound having a deodorizing activity against bad odors. The compound is represented by formula (I). In formula (I), R1, R2, R3, R4 and R5 are independently selected from the group consisting of a hydrogen atom, an alkyl group having 1 to 4 carbon atoms, an acyl group having 1 to 4 carbon atoms and a group represented by formula (II); R6 is selected from the group consisting of a hydrogen atom, an alkyl group having 1 to 4 carbon atoms, an acyl group having 1 to 4 carbon atoms, an acyloxy group having 1 to 4 carbon atoms, an alkenyl group having 2 to 4 carbon atoms, an aldehyde group having 1 to 4 carbon atoms and a group represented by formula (III); R7 is selected from the group consisting of a hydrogen atom, an alkoxy group having 1 to 4 carbon atoms, an acyl group having 1 to 4 carbon atoms, an acyloxy group having 1 to 4 carbon atoms and a group represented by formula (III); R8, R9 and R10 are independently selected from the group consisting of a hydrogen atom, an alkyl group having 1 to 4 carbon atoms and an acyl group having 1 to 4 carbon atoms; and R11 is selected from the group consisting of a hydrogen atom, an alkoxy group having 1 to 4 carbon atoms, an acyl group having 1 to 4 carbon atoms, and an acyloxy group having 1 to 4 carbon atoms.
Disclosed is a ketone accumulation inhibitor which can inhibit the accumulation of ketones which is caused by exercising. The ketone accumulation inhibitor comprises isomaltulose as an active ingredient.
A61P 3/10 - Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
66.
COMPOSITION FOR REDUCING OXIDATIVE STRESS AND/OR SIDE EFFECTS OCCURRING DURING CANCER CHEMOTHERAPY OR IMPROVING NUTRITIONAL STATUS DURING CANCER CHEMOTHERAPY
Provided is a composition for reducing oxidative stress and/or side effects occurring during cancer chemotherapy or improving a nutritional status during cancer chemotherapy. The composition is one for reducing oxidative stress and/or side effects occurring during cancer chemotherapy or improving nutritional status during cancer chemotherapy and comprises the following components (a) to (f): (a) an antioxidant agent; (b) at least one component selected from the group consisting of vitamin B1, vitamin B, vitamin B6, niacin, and pantothenic acid; (c) at least one component selected from the group consisting of folic acid, vitamin B12, and vitamin A; (d) zinc; (e) selenium; and (f) coenzyme Q10.
Provided is a composition for improving nutritional status, reducing frequency of fever and/or increasing immunocompetence of the elderly. The composition is a composition for improving nutritional status, reducing frequency of fever and/or increasing immunocompetence of the elderly and comprises the following components (a) to (e): (a) an antioxidant: (b) at least one component selected from the group consisting of vitamin B1, vitamin B2, vitamin B6, niacin and pantothenic acid; (c) at least one component selected from the group consisting of folic acid and vitamin B12; (d) zinc; and (e) selenium.
COMPOSITION FOR IMPROVING NUTRITIONAL STATUS OF THE ELDERLY, REDUCING FREQUENCY OF FEVER OF THE ELDERLY AND/OR INCREASING IMMUNOCOMPETENCE OF THE ELDERLY
Provided is a composition for improving the nutritional status, reducing the frequency of fever, and/or increasing the immunocompetence of the elderly. The composition is one for improving the nutritional status, reducing the frequency of fever, and/or increasing the immunocompetence of the elderly and comprises the following components (a) to (e): (a) an antioxidant agent; (b) at least one component selected from the group consisting of vitamin B1, vitamin B2, vitamin B6, niacin, and pantothenic acid; (c) at least one component selected from the group consisting of folic acid and vitamin B12; (d) zinc; and (e) selenium.
COMPOSITION FOR REDUCING OXIDATIVE STRESS AND/OR SIDE EFFECTS OCCURRING DURING CANCER CHEMOTHERAPY OR IMPROVING NUTRITIONAL STATUS DURING CANCER CHEMOTHERAPY
Provided is a composition for reducing oxidative stress and/or side effects occurring during cancer chemotherapy or improving nutritional status during cancer chemotherapy. The composition is a composition for reducing oxidative stress and/or side effects occurring during cancer chemotherapy or improving nutritional status during cancer chemotherapy and comprises the following components (a) to (f): (a) an antioxidant: (b) at least one component selected from the group consisting of vitamins B1, B2, B6, niacin and pantothenic acid; (c) at least one component selected from the group consisting of folic acid, vitamin B12 and vitamin A; (d) zinc; (e) selenium; and (f) coenzyme Q10.
Disclosed is a composition for reducing the levels or level of glucose, malondialdehyde-modified LDL, homocysteine, and/or C-reactive protein in the blood Specifically disclosed is a composition for reducing the level of at least one substance selected from the group consisting of glucose, malondialdehyde-modified LDL, homocysteine, and C-reactive protein in the blood, which comprises the following components (a) and (b) (a) at least one component selected from the group consisting of vitamin B12, vitamin B6, and folic acid, and (b) at least one component selected from the group consisting of zinc, selenium, and an antioxidant vitamin.
A61K 31/197 - Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
A61P 3/10 - Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
A61P 9/10 - Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Disclosed is a composition for reducing the level of glucose, a malondialdehyde-modified LDL, homocysteine and/or a C-reactive protein in the blood. Specifically disclosed is a composition for reducing the level of at least one substance selected from the group consisting of glucose, a malondialdehyde-modified LDL, homocysteine and a C-reactive protein in the blood, which comprises the following components (a) and (b): (a) at least one component selected from the group consisting of vitamin B12, vitamin B6 and folic acid; and (b) at least one component selected from the group consisting of zinc, selenium and an anti-oxidant vitamin.
A61K 31/197 - Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
A61P 3/10 - Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
A61P 9/10 - Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
DEODORANT COMPRISING DEODORIZING SUBSTANCE ORIGINATING IN SUGARCANE DISTILLATE AS THE ACTIVE INGREDIENT AND METHOD OF IMPROVING ODOR ORIGINATING IN SUGARCANE
It is intended to provide a deodorant which is a deodorant containing a deodorizing substance originating in sugarcane as the active ingredient, wherein the above-described deodorizing substance originating in sugarcane is a pot residue that has been obtained by distilling sugarcane juice or a solvent extract of sugarcane, treating the resultant distillate with column chromatography using a fixed support, further distilling the fraction obtained by the above treatment or a mixture of the fraction with water or a solvent mixture consisting of water with an alcohol, and completing the distillation when the alcohol concentration (volume/volume) in the pot residue attains 0% or more but not more than 10%. It is also intended to provide a method of improving the odor originating in sugarcane of a distillate obtained by distilling sugarcane juice or a solvent extract of sugarcane, which comprises treating the distillate by column chromatography using a fixed support, further distilling the fraction obtained by the above treatment or a mixture of the fraction with water or a solvent mixture consisting of water with an alcohol, and collecting the pot residue after completing the distillation when the alcohol concentration (volume/volume) in the pot residue attains 0% or more but not more than 10%.
A61K 8/97 - Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof, of undetermined constitution from algae, fungi, lichens or plantsCosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof, of undetermined constitution from derivatives thereof
The invention provides a sucrase activity inhibitor and a glucoamylase activity inhibitor comprising one or more saccharides selected from the group consisting of palatinose, trehalose and reduced palatinose. Further, the invention provides a food and a feed containing the sucrase activity inhibitor and/or the glucoamylase activity inhibitor.
